1. Home
2. ICD-10 Codes
3. Chapter - D50-D89
4. Section - D70-D77
5. Category - D70
6. D70.1

D70.1 - Agranulocytosis secondary to cancer chemotherapy

• Applicable to Agranulocytosis secondary to cancer chemotherapy
• The 2025 edition of ICD10-CM D70.1 became effective on October 1, 2024.
• This is the American ICD10-CM version of D70.1 - other international versions of ICD10 D70.1 may differ.
• D70.1 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code:

• code for adverse effect, if applicable, to identify drug (T45.1X5)

codeAlso

• underlying neoplasm

The following codes above D70.1 contain annotation back-references that may be applicable to D70.1:

• Chapter: D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
• Section: D70-D77 - Other disorders of blood and blood-forming organs
• Category: D70 - Neutropenia

Browse other similar CM codes:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.